Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Commentary
  • Published:

Homocysteine and vascular disease

Nature Medicine volume 2, pages 386–389 (1996)Cite this article

The discovery of hyperhomocysteinemia as a major factor in the pathogenesis of arteriosclerosis offers new strategies and opportunities for prevention and treatment.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. McCully, K.S. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56, 111–128 (1969).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Boushey, C.J., Beresford, S.A.A., Omenn, G.S. & Motulsky, A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274, 1049–1057 (1995).

    Article  CAS  Google Scholar 

  3. Kanwar, Y.S., Manaligod, J.R. & Wong, P.W.K. Morphologic studies in a patient with homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Pediatric Res. 10, 598–609 (1976).

    Article  CAS  Google Scholar 

  4. Selhub, J., Jacques, P.F., Wilson, P.W.F., Rush, D. & Rosenberg, I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270, 2693–2698 (1993).

    Article  CAS  Google Scholar 

  5. Nygard, O. et al. Total plasma homocysteine and cardiovascular risk profile. JAMA 274, 1526–1533 (1995).

    Article  CAS  Google Scholar 

  6. Stampfer, M.J. et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268, 877–881 (1992).

    Article  CAS  Google Scholar 

  7. McCully, K.S., Atherosclerosis, serum cholesterol and the homocysteine theory: A retrospective study of 194 consecutive autopsies. Am. J. Med. Sci. 299, 217–221 (1990).

    Article  CAS  Google Scholar 

  8. Nilsson, J., Regnstrom, J., Frostegard, J. & Stiko, A. Lipid oxidation and atherosclerosis. Herz 17, 263–269 (1992).

    CAS  PubMed  Google Scholar 

  9. Ross, R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362, 801–809 (1993).

    Article  CAS  Google Scholar 

  10. Naruszewicz, M., Mirkiewicz, E., Olszewski, A.J. & McCully, K.S. Thiolation of low-density lipoprotein by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages. Nutr. Metab. Cardiovasc. Dis. 4, 70–77 (1994).

    CAS  Google Scholar 

  11. McCully, K.S. Homocysteine metabolism in scurvy, growth and arteriosclerosis. Nature 231, 391–392 (1970).

    Article  Google Scholar 

  12. Clopath, P., Smith, V.C. & McCully, K.S. Growth promotion by homocysteic acid. Science 192, 372–374 (1976).

    Article  CAS  Google Scholar 

  13. McCully, K.S. Chemical pathology of homocysteine. I. Atherogenesis II. Carcinogenesis and homocysteine thiolactone metabolism. III. Cellular function and aging. Ann. Clin. Lab. Sci. 23, 477–493 (1993); 24, 27–59, 134–152 (1994).

    CAS  PubMed  Google Scholar 

  14. Matthias, D., Becker, C-H., Riezler, R. & Kindling, P.H. Homocysteine induced arteriosclerosis-like alterations of the aorta in nor-motensive and hypertensive rats following application of high doses of methionine. Atherosclerosis (in the press).

  15. Ubbink, J.B. et al. Effective homocysteine metabolism may protect South African blacks against coronary heart disease. Am. J. Clin. Nutr. 62, 802–808 (1995).

    Article  CAS  Google Scholar 

  16. Frosst, P. et al. A candidate genetic risk factor for vascular disease: A common mutation in methyl-enetetrahydrofolate reductase. Nature Genet. 10, 111–113 (1995).

    Article  CAS  Google Scholar 

  17. Mudd, S.H., Havlik, R., Levy, H.L., McKusick, V.A. & Feinleib, M. A study of cardiovascular risk in heterozygotes for homocystinuria. Am. J. Hum. Genet. 33, 883–893 (1981); 34, 1016–1021 (1982).

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Shipchandler, M.T. & Moore, E.G., Rapid, fully automated measurement of plasma homo cyst(e)ine with the Abbot IMX analyzer. Clin. Chem. 41, 991–994 (1995).

    CAS  PubMed  Google Scholar 

  19. Ubbink, J.B., VanderMerwe, A., Vermaak, W.J.H. & Delport, R. Homocysteinemia and the response to vitamin supplements. Clin. Investig. 71, 993–998 (1993).

    Article  CAS  Google Scholar 

  20. Ellis, J.M. & McCully, K.S. Prevention of myocardial infarction by vitamin B6. Res. Commun. Mol. Pathol. Pharmacol. 89, 208–220 (1995).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathology and Laboratory Medicine Service, Veterans Affairs Medical Center, 830 Chalkstone Avenue, Providence, Rhode Island, 02908-4799, USA

    Kilmer S. McCully

Authors
  1. Kilmer S. McCully
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCully, K. Homocysteine and vascular disease. Nat Med 2, 386–389 (1996). https://doi.org/10.1038/nm0496-386

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0496-386

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing